Puma Biotechnology (PBYI)
2.89 -0.12 (-3.99%) 14:31 ET [NASDAQ]
2.88 x 700 2.89 x 1,300
Realtime by (Cboe BZX)
2.88 x 700 2.89 x 1,300
Realtime 2.88 -0.13 (-4.32%) 09:30 ET
for Thu, Apr 3rd, 2025
Results
download Want to compare other data? Select Fields| Symbol | PBYI | IPHA | TNGX | ||
| Company | Puma Biotechnology | Innate Pharma S.A. ADR | Tango Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.87 | 1.9500 | 1.2800 | ||
| High | 2.95 | 2.0300 | 1.3400 | ||
| Low | 2.84 | 1.9100 | 1.2300 | ||
| Last | 2.89 | 1.9200 | 1.3000 | ||
| Change | -0.12 | +0.1300 | -0.0700 | ||
| % Change | -3.99% | +7.26% | -5.11% | ||
| Volume | 128,400 | 67,992 | 295,846 | ||
| 20-Day Average Volume | 357,188 | 22,444 | 783,103 | ||
| Previous Close | 3.01 | 1.7900 | 1.3700 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.27 | 1.9678 | 1.6880 | ||
| 20-Day Raw Stochastic | 7.79% | 44.44% | 2.66% | ||
| 20-Day Relative Strength | 42.68% | 49.58% | 29.33% | ||
| Weighted Alpha | -40.19 | -45.93 | -85.74 | ||
| Today's Opinion | 16% Buy | 40% Sell | 100% Sell | ||
| Previous Opinion | 32% Buy | 56% Sell | 100% Sell | ||
| Last Month's Opinion | 32% Buy | 24% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.94% since 03/27/25 | -0.51% since 03/27/25 | -22.05% since 03/27/25 | ||
| Low | 2.84 on 04/03/25 | 1.7600 on 04/02/25 | 1.2300 on 04/03/25 | ||
| High | 3.17 on 03/28/25 | 2.2100 on 04/02/25 | 1.6300 on 03/28/25 | ||
| 1-Month | |||||
| %Chg | -13.43% since 03/03/25 | -6.22% since 03/03/25 | -33.95% since 03/03/25 | ||
| Low | 2.84 on 04/03/25 | 1.7600 on 04/02/25 | 1.2300 on 04/03/25 | ||
| High | 3.75 on 03/06/25 | 2.2100 on 04/02/25 | 2.1750 on 03/06/25 | ||
| 3-Month | |||||
| %Chg | -1.69% since 01/03/25 | +4.81% since 01/03/25 | -60.16% since 01/03/25 | ||
| Low | 2.69 on 02/11/25 | 1.6000 on 01/15/25 | 1.2300 on 04/03/25 | ||
| High | 4.06 on 01/07/25 | 2.5900 on 02/24/25 | 3.6500 on 01/07/25 | ||
| 6-Month | |||||
| %Chg | +15.08% since 10/03/24 | -13.66% since 10/03/24 | -81.81% since 10/03/24 | ||
| Low | 2.32 on 11/18/24 | 1.2900 on 11/18/24 | 1.2300 on 04/03/25 | ||
| High | 4.06 on 01/07/25 | 3.5107 on 12/13/24 | 7.4646 on 10/18/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 149,329 | 150,056 | 148,108 | ||
| Shares Outstanding, K | 49,611 | 83,830 | 108,108 | ||
| Annual Sales | 230,470,000 | 21,770,000 | 42,070,000 | ||
| Annual Net Income | 30,280,000 | -53,530,000 | -130,300,000 | ||
| Last Quarter Sales | 59,080,000 | N/A | 4,120,000 | ||
| Last Quarter Net Income | 19,310,000 | N/A | -37,670,000 | ||
| 60-Month Beta | 1.34 | 0.31 | 1.03 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.43 on 02/27/25 | N/A | -0.35 on 02/27/25 | ||
| Latest Earnings Date | 05/01/25 | 03/27/25 | 05/14/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 4.80 | 0.00 | 0.00 | ||